,,ii #aai? ,,congress #a/ ,session ,s4 #cjgf ,,9 ,,! ,,s5ate ,,( ,,! ,,unit$ ,,/ates ,octob] #cj1 #bjbe ,mr4 ,mc,cormick 7= himself1 ,mr4 ,gallego1 ,mr4 ,ricketts1 ,mrs4 ,%ahe51 ,mr4 ,s*mitt1 ,ms4 ,slotk91 & ,mrs4 ,moody7 introduc$ ! foll[+ bill2 :i* 0 read twice & ref]r$ to ! ,committee on ! ,judici>y ,a ,,bill ,to am5d ! ,controll$ ,sub/ances ,act to p]man5tly s*$ule ! class ( #b-;b5zylb5zimidazole-opioids kn[n z nitaz5es1 & = o!r purposes4 #a4 ,%ort title ,?is ,act may be cit$ z ! ,nitaz5e ,control ,act4 #b4 ,f9d+s ,congress f9ds ! foll[+3 7#a7 #b-;,b5zylb5zimidazole opioids are a class ( syn!tic opioids fir/ syn!siz$ 9 ! #aiejs t exhibit significant pot5cy at ! mu-opioid receptor1 ) "s sub/ances exce$+ ! pot5cy ( f5tanyl4 7#b7 ,! ,drug ,en=cem5t ,adm9i/ration has tempor>ily or p]man5tly s*$ul$ multiple #b-;b5zylb5zimidazole opioids comp\nds "u s*$ule ,i ( section #bjb7;c7 ( ! ,controll$ ,sub/ances ,act 7#ba ,u4,s4,c4 #hab7;c77 due to _! high abuse pot5tial & lack ( accept$ m$ical use4 7#c7 ,nitaz5es & relat$ comp\nds h em]g$ 9 ! illicit drug supply z design] drugs & contribute to ov]dose & fatal poison+s 9 ! ,unit$ ,/ates4 7#d7 ,a class-wide p]man5t s*$ul+ ( #b-;b5zylb5zimidazole opioids is necess>y to preemptively address ! prolif]ation ( new analogs1 /reaml9e en=cem5t1 & protect public heal?4 7#e7 ,! ,,halt ,f5tanyl ,act 7#bh ,u4,s4,c4 #hja note2 ,public ,law #aai-bf7 creat$ pa?ways = rese>* us+ s*$ule ,i controll$ sub/ances t apply to s*$ul$ nitaz5es4 #c4 ,s*$ule ,i classification ( nitaz5es 7a7 ,am5dm5t ,s*$ule ,i ( section #bjb7;c7 ( ! ,controll$ ,sub/ances ,act 7#ba ,u4,s4,c4 #hab7;c77 is am5d$ by add+ at ! end ! foll[+3 7f7 7#a7 ,unless specifically exempt$ or unless li/$ 9 ano!r s*$ule1 any mat]ial1 comp\nd1 mixture1 or prep>ation :i* conta9s any quantity ( a #b-;b5zylb5zimidazole opioid1 or :i* conta9s ! salts1 isom]s1 & salts ( isom]s ( a #b-;b5zylb5zimidazole opioid4 7#b7 ,= purposes ( p>agraph 7#a71 ! t]m #b-;b5zylb5zimidazole opioid includes ! foll[+3 7,a7 ,a sub/ance t is /ructurally relat$ to #b-;b5zylb5zimidazole ) ! foll[+ modifications3 7i7 ,at ! #a-position1 sub/itution ) an alkyl l9k] connect$ to a sub/itut$ am9e gr\p conta9+ hydrog51 alkyl1 alk5yl1 or het]o>yl gr\p1 su* z a morphil9o1 pyrrolid9o1 or pip]id9yl gr\ps1 :e!r or n fur!r sub/itut$4 7ii7 ,at ! #b-position-- 7,i7 replacem5t ( ! alkyl portion ( ! b5zyl gr\p ) a sub/itut$ or unsub/itut$ alkyl1 alkoxy1 c>bamates gr\p1 nitrog51 sulfur1 or oxyg5 atom2 or 7,,ii7 replacem5t ( ! ph5yl portion ( ! b5zyl gr\p ) an aryl or het]o>yl gr\p4 7iii7 ,sub/itution on ! ph5yl portion ( ! b5zimidazole r+ ) a hydrog5 atom1 halog51 nitro1 cyano1 sub/itut$ or unsub/itut$ amide1 am9e1 alkyl1 alkoxy1 aryl1 or het]o>yl gr\p4 7iv7 ,at ! #f-position1 sub/itution ) hydrog51 nitro1 trifluorome?yl1 me?oxy1 trifluorome?oxy1 cyano1 & halog5 gr\ps4 7,b7 ,a sub/ance t exhibits agoni/ activity at ! mu-opioid receptor4 7,c7 ,etonitaz5e1 clonitaz5e1 metonitaz5e1 isotonitaz5e1 protonitaz5e1 butonitaz5e1 etodesnitaz5e1 flunitaz5e1 ,n-pyrrolid9o etonitaz5e1 ,n-dese?yl isotonitaz5e1 & ,n-pip]id9yl etonitaz5e4 4 7b7 ,removal ( tempor>y /atus ,any sub/ance includ$ 9 ! am5dm5t made by subsection 7a7 t 0 tempor>ily s*$ul$ "u section #bja7;h7 ( ! ,controll$ ,sub/ances ,act 7#ba ,u4,s4,c4 #haa7;h77 %all be deem$ p]man5tly s*$ul$ & subject to ! requirem5ts ( s*$ule ,i ( section #bjb7;c7 ( t ,act 7#ba ,u4,s4,c4 #hab7;c77 z ( ! date ( enactm5t ( ?is ,act4 7c7 ,rule ( con/ruction ,no?+ 9 ?is subsection %all be con/ru$ to au?orize ! initiation ( new rese>* us+ #b-;b5zylb5zimidazole opioids1 z def9$ 9 subsection 7f7 ( s*$ule ,i ( section #bjb7;c7 ( ! ,controll$ ,sub/ances ,act 7#ba ,u4,s4,c4 #hab7;c771 z add$ by subsection 7a7 ( ?is section1 )\t prop] regi/ration & s*$ul+ compliance4